Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways

Jamie F Lu1, Frederick Luk, Joyce Gong

  • 1School of Pharmacy, Graduate School of Health, University of Technology, Sydney, NSW 2007, Australia.

Insights

Multidrug resistance (MDR) can spread between cancer cells through microparticles. This study shows functional MRP1 transfer via microparticles, impacting chemotherapy effectiveness and tumor resistance.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Multidrug resistance (MDR) significantly hinders chemotherapy efficacy in cancer treatment.
  • ATP-dependent transmembrane proteins, P-glycoprotein (P-gp) and Multidrug Resistance-Associated Protein 1 (MRP1), are key mediators of MDR by exporting chemotherapeutics.
  • Understanding MDR acquisition and dissemination is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the intercellular transfer of functional Multidrug Resistance-Associated Protein 1 (MRP1) via microparticles (MPs).
  • To explore the impact of microparticle-mediated transfer on drug sensitivity and resistance profiles in recipient cells.
  • To elucidate the role of microparticles in the dissemination of multidrug resistance traits in cancer.

Main Methods:

  • Overexpression of MRP1 in drug-resistant cells and subsequent shedding of microparticles (MPs).
  • Incubation of drug-sensitive recipient cells with shed MPs.
  • Assessment of P-gp and MRP1 functionality and drug resistance in recipient cells over time.
  • Analysis of the re-templating of resistance profiles by P-gp-dominant MPs on MRP1-dominant recipient cells.

Main Results:

  • Demonstrated successful transfer and time-dependent functionality of MRP1 into drug-sensitive leukemia cells via MPs.
  • Confirmed the transfer and functionality of P-gp in drug-sensitive recipient cells.
  • Observed that MPs from P-gp-dominant cells can alter pre-existing MRP1-dominant resistance profiles in recipient cells.

Conclusions:

  • Microparticle-mediated intercellular transfer is a mechanism for the acquisition and dissemination of functional MRP1.
  • This process contributes to the development of multidrug resistance phenotypes in cancer cells.
  • Findings suggest novel strategies targeting microparticle transfer for overcoming MDR and other acquired traits in oncology.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...